CD24 and Nanog expression in Stem Cells in Glioblastoma: Correlation with Response to Chemoradiation and Overall Survival

BACKGROUND AND AIM: Glioblastoma (GBM) is one of the most common and aggressive brain tumors with a median survival of 12-14 months. The aim of present study was to evaluate the gene expression profile of stem cell markers Nanog and CD24 in GBM and to determine its relationship to outcome in terms o...

Descripción completa

Detalles Bibliográficos
Autores principales: Soni, Priyanka, Qayoom, Sumaira, Husain, Nuzhat, Kumar, Praveen, Chandra, Anil, Ojha, Bal Krishan, Gupta, Rakesh Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697483/
https://www.ncbi.nlm.nih.gov/pubmed/28843258
http://dx.doi.org/10.22034/APJCP.2017.18.8.2215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5697483/
https://www.ncbi.nlm.nih.gov/pubmed/28843258
http://dx.doi.org/10.22034/APJCP.2017.18.8.2215

Ejemplares similares